CJC-1295 No DAC & GHRP-2 Blend – 50 Vials at 30% Off

Product Overview

Revo Peptide is proud to offer the CJC-1295 No DAC & GHRP-2 Blend in a premium 50-vial bulk pack — one of the most sought-after dual-peptide research combinations available for sale online today. Designed exclusively for qualified laboratory researchers, this blended formulation delivers two well-characterized growth hormone-related peptides in a single, convenient vial. At 30% off standard per-unit pricing, this bulk configuration represents outstanding value for high-volume research programs. Each vial is independently quality-verified and lyophilized for maximum stability.

Peptide Structure & Amino Acid Sequence

This blend contains two distinct peptide compounds with fully documented primary sequences:

• CJC-1295 No DAC: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ — a 30-amino-acid modified GHRH analogue lacking the Drug Affinity Complex (DAC) modification, resulting in a shorter half-life and pulsatile release profile preferred in certain research protocols.
• GHRP-2: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ — a synthetic hexapeptide ghrelin receptor agonist with a well-established research profile in growth hormone secretagogue studies.

Together, these sequences create a synergistic dual-compound system of significant interest to endocrinological and peptide pharmacology researchers.

Chemical & Physical Characteristics

• CJC-1295 No DAC Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• CJC-1295 No DAC Molecular Weight: 3,367.79 g/mol
• GHRP-2 Molecular Formula: C₄₅H₅₅N₉O₆
• GHRP-2 Molecular Weight: 817.97 g/mol
• Blend per Vial: 2 mg CJC-1295 No DAC + 2 mg GHRP-2 = 4 mg total active peptide
• Physical Appearance: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffers; specific solubility conditions should be determined by the qualified researcher according to institutional protocols

Purity & Analytical Verification (HPLC & MS)

Every batch of the CJC-1295 No DAC & GHRP-2 Blend produced and supplied by Revo Peptide is independently verified to a minimum purity of ≥98% by reverse-phase High-Performance Liquid Chromatography (HPLC). Mass Spectrometry (MS) confirmation is also performed to validate the molecular identity of both peptide components, ensuring that the correct sequences and molecular weights are present in each vial. Researchers can request batch-specific Certificates of Analysis (CoA) to support documentation and reproducibility requirements in their laboratory workflows.

Quality Control & Lyophilization Integrity

Revo Peptide applies rigorous multi-stage quality control procedures across every production run. Both CJC-1295 No DAC and GHRP-2 are co-lyophilized using pharmaceutical-grade freeze-drying protocols that preserve peptide integrity, minimize moisture content, and extend shelf life under appropriate storage conditions. Each vial is sealed under inert atmosphere to prevent oxidation and contamination. Batch traceability is maintained from synthesis through to final packaging, ensuring consistent quality across all 50 vials in this bulk configuration.

Safety, Handling & Laboratory Precautions

This product is intended solely for use by trained scientific professionals in a controlled laboratory environment. Researchers should adhere to all applicable institutional biosafety guidelines when handling lyophilized peptide materials. Standard laboratory personal protective equipment (PPE) — including gloves, safety glasses, and a lab coat — should be worn at all times. Avoid inhalation of lyophilized powder. This product is not approved for human or animal administration, and any use outside of a research context is strictly prohibited.

Reconstitution, Packaging & Storage

Each vial in this 50-vial bulk pack contains 4 mg of co-lyophilized peptide blend (2 mg CJC-1295 No DAC + 2 mg GHRP-2). Reconstitution should be performed by a qualified researcher using an appropriate sterile aqueous solvent as determined by the research protocol and institutional guidelines. Store lyophilized peptide at –20°C in a dry, dark environment. Avoid repeated freeze-thaw cycles. Once reconstituted, store at 4°C and use within a timeframe consistent with established laboratory best practices. Packaging is designed to maintain vial integrity during transit and long-term storage.

Intended Research Use & Market Positioning

The CJC-1295 No DAC & GHRP-2 Blend is positioned as a premier dual-secretagogue research tool for scientists investigating growth hormone axis signalling, pulsatile GH release dynamics, and related neuroendocrine mechanisms. The combination of a GHRH analogue (CJC-1295 No DAC) with a ghrelin receptor agonist (GHRP-2) makes this blend a valuable asset in in vitro and ex vivo experimental models. Revo Peptide supplies this blend to academic institutions, pharmaceutical researchers, and private laboratories seeking reliable, high-purity peptide reagents at competitive pricing.

Ordering, Availability & Fulfillment

This 50-vial bulk pack is available to buy online now at Revo Peptide with fast order processing and secure fulfillment. At 30% off standard pricing, this is one of the best-value research peptide offers currently available for sale in this category. Orders are dispatched promptly following payment verification, with discreet and protective packaging to ensure safe delivery. For researchers requiring even larger quantities, wholesale pricing inquiries are welcome — contact Revo Peptide directly for volume-based quotations and custom fulfillment arrangements.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The CJC-1295 No DAC & GHRP-2 Blend is sold exclusively as a laboratory research reagent. Revo Peptide makes no representations regarding the suitability of this product for any therapeutic, diagnostic, or consumptive purpose. All purchasers are solely responsible for ensuring compliance with applicable local, national, and international regulations governing the procurement, possession, and use of research peptides. This product has not been evaluated or approved by any regulatory authority for use in humans or animals.